IRhythm Technologies, Inc.
IRTC
株式のランク
#4223
iRhythm Technologies, Inc. is a digital healthcare enterprise dedicated to... iRhythm Technologies, Inc. is a digital healthcare enterprise dedicated to offering portable electrocardiogram (ECG) monitoring solutions to individuals in the United States who face the risk of cardiac arrhythmias. Its primary offering, the Zio service, provides a comprehensive ambulatory cardiac monitoring system. This system ingeniously combines a wireless, patch-based, and wearable biosensor—specifically embodied in products like the Zio XT and AT monitors—with a sophisticated cloud-based data analysis platform. These single-use biosensors precisely record a patient's heartbeats and ECG data, thereby enabling medical professionals to effectively oversee patient heart health and accurately diagnose arrhythmias. Furthermore, iRhythm maintains a strategic development partnership with Verily Life Sciences LLC, focused on pioneering future atrial fibrillation screening, detection, and monitoring innovations. Founded in 2006, the company maintains its corporate headquarters in San Francisco, California.
株価
$114.59
最終同期: 2026-10-20
時価総額
$3.78B
変化（1日）
4.55%
変化（1年）
-35.69%
国
US
取引 IRhythm Technologies, Inc. (IRTC)
カテゴリー
Healthcare
IRhythm Technologies, Inc.（IRTC）のP/B比率
October 2026 時点のP/B比率 TTM: 18.76
IRhythm Technologies, Inc. の最新の財務報告および株価によると、現在のP/B比率（TTM）は 18.76 です。2023 年末時点でのP/B比率は 15.55 でした。
IRhythm Technologies, Inc. の P/B 比率の履歴（2013 ～ 2026）
各年末時点のP/B比率
| 年 | P/B比率 | 変化 |
|---|---|---|
| 2026 (TTM) | 18.76 | -39.38% |
| 2024 | 30.94 | 98.94% |
| 2023 | 15.55 | 33.11% |
| 2022 | 11.69 | -5.38% |
| 2021 | 12.35 | -35.92% |
| 2020 | 19.27 | 51.69% |
| 2019 | 12.70 | -58.34% |
| 2018 | 30.49 | 91.28% |
| 2017 | 15.94 | 830.56% |
| 2016 | 1.71 | -145.25% |
| 2015 | -3.79 | -20.74% |
| 2014 | -4.78 | -166.32% |
| 2013 | 7.20 | 0.00% |
同業他社のP/B比率
| 企業 | P/B比率 | P/B比率の差 | 国 |
|---|---|---|---|
| 3.5116 | -81.28% |
US
|
|
| 2.0146 | -89.26% |
IE
|
|
| 4.5025 | -76.00% |
US
|
|
| 2.5486 | -86.41% |
US
|
|
| - | - |
DE
|
